Report: U.S. government incentives will spur robust infusion pump sales

Government initiatives will likely drive robust growth in the U.S. infusion pump market over the next 5 years, Millennium Research Group predicts, calculating that this stimulus will propel sales in the sector to $3.6 billion by 2017. Government payments to boost the use of health information technology will increase sales of high-tech "smart" infusion pumps that can be integrated with electronic medical record systems, Millennium believes. As well, incentive bonuses from the Centers for Medicare and Medicaid Services will spur sales of infusion pumps specifically designed to help manage pain. Release

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.